GlaxoSmithKline

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Public

Established: 1929-01-01

Employees: 70.2K

Market Cap: $90B

Website: http://www.gsk.com

Introduction: GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Clinical Trials

A Cross-sectional Study on COPD Prevalence

Completed

Conditions: Pulmonary Disease, Chronic Obstructive

Interventions: Procedure: Medical tests
Other: Questionnaire

First Posted Date: 2017-01-23

Last Posted Date: 2019-06-28

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 9362

Registration Number: NCT03028207

Locations: 🇪🇸
GSK Investigational Site, Zaragoza, Spain

A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3389404 in Chronic Hepatitis B (CHB) Subjects

Phase 2

Completed

Conditions: Hepatitis B

Interventions: Drug: GSK3389404
Drug: Placebo

First Posted Date: 2017-01-13

Last Posted Date: 2020-10-01

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 78

Registration Number: NCT03020745

Locations: 🇸🇬
GSK Investigational Site, Singapore, Singapore

Study of Mepolizumab Safety Syringe in Asthmatics

Phase 3

Completed

Conditions: Asthma

Interventions: Drug: Mepolizumab

First Posted Date: 2017-01-13

Last Posted Date: 2019-07-23

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 56

Registration Number: NCT03021304

Locations: 🇸🇪
GSK Investigational Site, Stockholm, Sweden

Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Eosinophilia Among Primary Care Patients

Completed

Conditions: Pulmonary Disease, Chronic Obstructive

Interventions: Other: Minimal questionnaire
Other: Medical interview
Other: CAT
Procedure: Blood test
Other: anthropometric measures
Other: Oximetry

First Posted Date: 2017-01-12

Last Posted Date: 2022-04-12

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 800

Registration Number: NCT03018808

Locations: 🇧🇷
GSK Investigational Site, Botucatu, São Paulo, Brazil

A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes Mellitus

Phase 3

Withdrawn

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Albiglutide
Drug: Placebo

First Posted Date: 2017-01-10

Last Posted Date: 2019-01-17

Lead Sponsor: GlaxoSmithKline

Registration Number: NCT03015519

Locations: 🇺🇸
GSK Investigational Site, El Paso, Texas, United States

A Study to Compare the Pharmacokinetics of Mepolizumab as a Liquid Drug in a Safety Syringe or an Autoinjector Versus Lyophilised Drug

Phase 3

Completed

Conditions: Asthma

Interventions: Biological: Lyophilized mepolizumab
Biological: Liquid mepolizumab
Device: Prefilled Safety Syringe
Device: Prefilled autoinjector

First Posted Date: 2017-01-09

Last Posted Date: 2019-12-03

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 246

Registration Number: NCT03014674

Locations: 🇬🇧
GSK Investigational Site, Harrow, Middlesex, United Kingdom

Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma

Phase 2

Completed

Conditions: Asthma

Interventions: Drug: Placebo
Drug: UMEC
Drug: Fluticasone Furoate
Drug: Albuterol/salbutamol

First Posted Date: 2017-01-06

Last Posted Date: 2020-10-28

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 425

Registration Number: NCT03012061

Locations: 🇷🇺
GSK Investigational Site, Yaroslavl, Russian Federation

Consumer Perception of an Experimental Mouthwash After a Single Use in Dry Mouth Subjects

Not Applicable

Completed

Conditions: Xerostomia

Interventions: Other: Biotene mouthwash
Other: Bottled mineral water

First Posted Date: 2016-12-29

Last Posted Date: 2018-07-19

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 56

Registration Number: NCT03005041

Locations: 🇺🇸
GSK Investigational Site, Boston, Massachusetts, United States

To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold

Phase 2

Completed

Conditions: Common Cold

Interventions: Drug: Carbomer 980 (1146A)
Other: Placebo

First Posted Date: 2016-12-29

Last Posted Date: 2018-06-19

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 171

Registration Number: NCT03005067

Locations: 🇺🇸
GSK Investigational Site, Bellevue, Washington, United States

A Study of GSK2981278 Ointment in Subjects With Plaque Psoriasis

Phase 1

Completed

Conditions: Psoriasis

Interventions: Drug: GSK2981278 ointment
Drug: Vehicle ointment

First Posted Date: 2016-12-29

Last Posted Date: 2019-04-18

Lead Sponsor: GlaxoSmithKline

Target Recruit Count: 8

Registration Number: NCT03004846

Locations: 🇩🇪
GSK Investigational Site, Hamburg, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy